Pancreatic Adenocarcinoma Therapeutic Targets Revealed by Tumor-Stroma Cross-Talk Analyses in Patient-Derived Xenografts
2017 · Cell Reports · 194 citations
https://doi.org/10.1016/j.celrep.2017.11.003
R
Rémy Nicolle
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
215
Papers
3.4K
Citations
30
h-index
53
i10-index
Rémy Nicolle is an academic researcher from Centre National de la Recherche Scientifique. The author has contributed to research in topics: Pancreatic and Hepatic Oncology Research & Cancer Genomics and Diagnostics & Immune cells in cancer. The author has an h-index of 30, co-authored 183 publications.
ORCID: 0000-0001-8084-1173Papers by this author
worksIntegrated molecular characterization of chondrosarcoma reveals critical determinants of disease progression
2019 · Nature Communications · 96 citations
https://doi.org/10.1038/s41467-019-12525-7
A transcriptomic signature to predict adjuvant gemcitabine sensitivity in pancreatic adenocarcinoma
2020 · Annals of Oncology · 79 citations
https://doi.org/10.1016/j.annonc.2020.10.601
Establishment of a pancreatic adenocarcinoma molecular gradient (PAMG) that predicts the clinical outcome of pancreatic cancer
2020 · EBioMedicine · 77 citations
https://doi.org/10.1016/j.ebiom.2020.102858
Gene expression profiling of patient‐derived pancreatic cancer xenografts predicts sensitivity to the <scp>BET</scp> bromodomain inhibitor <scp>JQ</scp> 1: implications for individualized medicine efforts
2017 · EMBO Molecular Medicine · 68 citations
https://doi.org/10.15252/emmm.201606975
Pacpaint: a histology-based deep learning model uncovers the extensive intratumor molecular heterogeneity of pancreatic adenocarcinoma
2023 · Nature Communications · 58 citations
https://doi.org/10.1038/s41467-023-39026-y
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat